Lam Research Authorizes $25 Billion Buyback With No End Date

$25 billion

New repurchase ceiling

$0.33

Declared dividend per share

No end date

Repurchase program

Lam Research’s board authorized up to $25 billion of share repurchases on November 5, adding capacity to its existing program without setting an expiration date. The Lam Research buyback is permission to purchase stock, not a commitment to spend the full amount. The semiconductor-equipment company also declared a $0.33 quarterly dividend payable January 6, 2027.

According to Lam’s announcement, the repurchase program supplements the remaining balance of the previous authorization and can be suspended or discontinued at any time. The statement provides no fixed completion date or mandated spending schedule. The dividend has a separate timetable: shareholders of record on December 2, 2026, are entitled to the declared payment.

What the board authorized—and what it did not

Lam can buy shares in open-market or private transactions, including through derivative contracts and structured repurchase agreements. That flexibility concerns the method of execution. It does not establish how many shares have already been purchased under the new authorization, what prices the company will pay or whether the entire ceiling will be used.

The release does not quantify the remaining balance under the previous authorization. Consequently, adding an assumed old balance to the new $25 billion would produce an unsupported total. Similarly, the authorization cannot be translated into a fixed share count without an assumed purchase price; actual prices would depend on execution.

Chief Financial Officer Doug Bettinger described the announcement as reinforcing Lam’s capital-allocation plan and commitment to return value through dividends and repurchases. His confidence in cash generation is management’s assessment. The authorization itself is not a new revenue contract and does not establish additional customer spending on semiconductor fabrication equipment.

The dividend dates are separate from buyback timing

The $0.33 dividend is an amount per common share, unlike the aggregate $25 billion buyback ceiling. Combining the two numbers without an eligible share count would mix units. Nor does multiplying the quarterly dividend by four establish an approved full-year payment: Lam explicitly says future dividends require board review and approval.

The record date and payment date also serve different functions. December 2 identifies the holders of record for this declared dividend; January 6 is the scheduled distribution. The release does not supply an ex-dividend date. This report therefore does not invent one or provide trading instructions based on the record date.

Schwab’s November 6 morning commentary reported Lam shares up more than 11% before the opening bell after the announcement. That observation is not a closing price or a measured full-day return. Our earlier company-movers report covered the initial earnings and capital-return tape; this article examines the authorization’s actual terms.

By the numbers: shareholder votes add governance context

Lam’s November 5 Form 8-K, reproduced by Stock Titan, also reports results from the November 3 annual meeting. All 10 director nominees were elected. An advisory vote on named executive-officer compensation received 93.12% support, and ratification of KPMG as fiscal 2027 auditor received 99.33%, using the filing’s reported percentages of votes cast.

A shareholder proposal concerning the right to call a special shareholder meeting received 42.22% support and was not approved. The gap between that support and the compensation vote was 50.90 percentage points, a TBR calculation. The chart compares the filing’s own vote percentages; it does not portray a shareholder vote on the new buyback.

That distinction matters because a capital-return headline and annual-meeting results appeared in the same filing but describe different actions. The board approved repurchase capacity. Shareholders voted on directors, compensation, the auditor and the special-meeting proposal. Strong support for one ballot item cannot be relabeled an endorsement of another corporate decision.

Analysis: authorization is not an earnings forecast

Repurchases can reduce the number of shares outstanding when executed, but the effect on per-share results depends on the quantity, price, timing and other share issuance. An authorization alone does not guarantee a higher stock price or improved operating profit. The missing execution details are material, not merely technical footnotes.

For a business exposed to capital-intensive chip manufacturing, borrowing costs and customer investment plans remain relevant. The Federal Reserve tracker follows the policy backdrop, while our November 6 market report describes the wider technology rebound. Neither supplies evidence that Lam has already spent the newly authorized amount.

The verified news is therefore specific: a $25 billion addition to repurchase capacity, no expiration date, no purchase obligation and a separately declared $0.33 dividend. Subsequent financial disclosures, rather than the size of the authorization alone, will show how much of that capacity becomes completed repurchases.

Sources

• Lam Research: November 5 buyback and dividend announcement
• Lam Research Form 8-K, November 5 (full document reproduced by Stock Titan)
• Charles Schwab: November 6 morning market report, 9:15 a.m. EST